Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer

NCT04931017

Conditions
Lung Carcinoma, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • BC Cancer Research Centre Vancouver, British Columbia, Canada
  • University of British Columbia Hospital Vancouver, British Columbia, Canada
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

NCT04305613

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • The Brigham and Women's Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Rutger's University / Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

NCT04472949

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View all 14 locations
View Trial Details
Active, Not Recruiting

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

NCT04986670

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • The James Cancer Hospital Columbus, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions